Found 2 clinical trials
Minocycline in MS: Confirmation of Benefit
Trial participants will include men and women, aged 18-60 years who have had a first demyelinating event within the previous 180 days and who have brain magnetic resonance imaging (MRI) with at least two brain T2 lesions which are at least 3 mm in diameter, and at least one of …
- 0 views
- 16 Feb, 2024
- 1 location
Effect of Minocycline on Delirium Incidence in Critically Ill Patients
Patients in the intensive care unit (ICU) under mechanical ventilation and older age are at higher risk for the development of delirium. Several studies suggest that minocycline, through its anti-inflammatory effect, was able to prevent neuronal dysfunction in different models of ICU-related diseases. Thus, the present study aimed to evaluate …
- 0 views
- 16 Feb, 2024
- 1 location